drugset / Trial / NCT02343172
Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
NaSingle-groupOpen-labelTreatment
Summary
To determine the MTD/RP2D of the HDM201 and LEE011 combination and evaluate whether the combination is safe and has beneficial effects in patients with liposarcoma.
Timeline
- Start
- 2015-03-13
- Primary completion
- 2019-10-16
- Completion
- 2019-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribociclib | Small molecule | — | Oral |
| Subject | Siremadlin | Small molecule | — | Oral |